Joseph Burnette, MD
Payments from drug & device makers
Across 51 payments — averaging $65.45 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Intuitive Surgical$901
- Medical Device Business Services, Inc.$786
- Apollo Endosurgery US Inc$694
- Covidien LP$236
- Medtronic$144
- Lucid Diagnostics Inc.$116
- plus $461 from 13 others
What the payments were for
- Travel & lodging$1,91757%
- Food & beverage$1,42143%
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Intuitive Surgical | 12 | $901 |
| Medical Device Business Services, Inc. | 7 | $786 |
| Apollo Endosurgery US Inc | 1 | $694 |
| Covidien LP | 4 | $236 |
| Medtronic | 2 | $144 |
| Lucid Diagnostics Inc. | 2 | $116 |
| Pentax Of America, Inc. | 3 | $79 |
| Vertex | 3 | $71 |
| Johnson & Johnson | 3 | $69 |
| Regeneron Healthcare Solutions, Inc. | 2 | $47 |
| Mauna Kea Technologies, Inc. | 2 | $40 |
| Smith+Nephew | 3 | $35 |
| TELA Bio, Inc. | 1 | $30 |
| Takeda Pharmaceuticals U.S.A., Inc. | 1 | $16 |
| Osiris Therapeutics Inc. | 1 | $16 |
| La Jolla Pharmaceutical Company | 1 | $16 |
| Capsovision, Inc. | 1 | $14 |
| Paratek Pharmaceuticals, Inc. | 1 | $13 |
| Teleflex LLC | 1 | $13 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
How this compares
$3,338 in reported general payments places this provider in the 60th percentile of 855 surgery providers in Georgia.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| Sucralfate | 250 | $14,898 |
| LinzessLinaclotide | 16 | $8,337 |
| Pantoprazole Sodium | 304 | $2,605 |
| Budesonide DrBudesonide | 15 | $1,334 |
| CholestyramineCholestyramine (With Sugar) | 27 | $1,194 |
| Omeprazole | 26 | $364 |
| Hydrocodone-AcetaminophenHydrocodone/Acetaminophen | 20 | $138 |
| Metronidazole | 14 | $130 |
| Famotidine | 16 | $107 |
Paid to pharmacies, not to this prescriber.
Other surgery in Macon
- Danny VaughnMacon$89K
- Idelberto BadellAtlanta$3.9M
- Chad CopperGainesville$999K
- Zachary KlaassenAugusta$763K
- Kendra GrubbAtlanta$761K
- Stephen OdomAustell$599K
- Fritz Jean-PierreMarietta$464K
- Nelson RoyallGainesville$415K
- Denise LoAtlanta$309K
- Christian LarsenAtlanta$308K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.